Dear Colleagues from the ESC Working Group on Atherosclerosis and Vascular Biology,

We hope your 2025 is off to a fantastic start! As summer approaches, we wish you continued success in all your professional and personal endeavours.

We're excited to see growing engagement with our new X page @ESCWGAVBChair! To help it thrive and reach the wider community of atherosclerosis and vascular biology enthusiasts, we’d love you to support us, follow us, engage, and share our updates.

We encourage you to also join us at LinkedIn and stay connected through our #AtheroMatters LinkedIn group.

The ESC Congress 2025 – The Event of the Year!

Get ready for the ESC Congress 2025, taking place in Madrid from 29 August to 1 September, in collaboration with the World Congress of Cardiology, the flagship event for the global cardiovascular community.

We're thrilled to announce that the scientific programme is now available online! This year’s agenda features a rich selection of sessions dedicated to GLOBAL HEALTH, translational science, atherosclerosis, and vascular biology, testament to the growing recognition of our field. Expect cutting-edge research, thought-provoking discussions, and opportunities to shape the future of cardiovascular science.

Don’t miss this chance to connect with leading experts, present your work, and highlight the latest breakthroughs. Let’s bring bold, innovative science to the ESC stage and make our specialty more visible than ever.

Mark your calendar — and dive into the exciting scientific programme today.

Working Group Talk

"Decoding Lipoprotein(a): From Atherosclerosis to Clinical Implications" on 11 June from 17:00-18:00 CEST.

Join us for a focused session on Lipoprotein(a) and its impact on atherosclerosis and coronary artery disease. Designed for clinicians and researchers, this talk will cover advanced testing, clinical challenges, and practical strategies for integrating Lp(a) into patient care.

Follow exciting talks by the experts in the field, explore real-world applications, and engage in interactive discussions — all aimed at enhancing your approach to cardiovascular risk management.

Don’t miss this opportunity to translate cutting-edge science into practice.

Recommended Readings

We are excited to highlight an updated meta-analysis on the efficacy and safety of colchicine for secondary prevention of vascular events, published in the European Heart Journal. A commentary on this key paper, written by Simon Kraler & Luca Liberale, is available here: ESC Working Group Commentaries.

Additionally, we recommend:

1. d’Entremont M-A, Poorthuis MHF, Fiolet ATL, Amarenco P, Boczar KE, Buysschaert I, et al. Colchicine for secondary prevention of vascular events: a meta-analysis of trials. Eur Heart J 2025; online ahead of print
2. Ministrini S, Puspitasari YM, Beer G, Schwarz L, Niederberger R, Kraler S, Wenzl FA, Katan M, Bacigaluppi M, Semerano A, Akhmedov A, Bengs S, Montecucco F, Lüscher TF, Camici GG, Liberale L. Endothelial JCAD Worsens Acute Ischemic Stroke Outcomes by Enhancing Inflammation in Response to Ischemia/Reperfusion. JACC Basic Transl Sci. 2025 Feb;10(2):187-199. doi: 10.1016/j.jacbts.2024.09.009.

We hope these papers will inspire your work!

Stay Connected!

Your input helps us grow and to provide relevant content. If you have suggestions for future newsletters or topics you'd like to see covered, please don’t hesitate to contact Luca Liberale at luca.liberale@unige.it  with in the subject line: WG Atherosclerosis Vascular Biology.

Thank you for being such a vital part of our community. Let’s keep the conversation going on X (@ESCWGAVBChair) and LinkedIn (#AtheroMatters), and we hope to connect with many of you in person at upcoming conferences!

Luca, Holger, Simon & Elena
On behalf of the ESC Working Group on Atherosclerosis and Vascular Biology